Table 2.

Intrapancreatic localization of all included pancreatic tumors n (%)

Diagnosis	Tumor localization
	Pancreatic head	Pancreatic body	Pancreatic tail	> 1 pancreatic area	Pancreas unspecified	Papilla vateri
Pancreatic cancer	362	50	44	11	1	1
	(77.2)	(10.7)	(9.4)	(2.4)	(0.2)	(0.2)
Serous cystadenoma	8	9	9	4	1	0
	(25.8)	(29.0)	(29.0)	(12.9)	(3.2)	(0.0)
Mucinous cystadenoma	2	6	9	1	1	1
	(10.0)	(30.0)	(45.0)	(5.0)	(5.0)	(5.0)
Non-invasive IPMN	33	2	3	6	2	2
	(68.8)	(4.2)	(6.3)	(12.5)	(4.2)	(4.2)
Invasive IPMN	26	3	4	4	0	0
	(70.3)	(8.1)	(10.8)	(10.8)	(0.0)	(0.0)
Low stage neuroendocrine neoplasia	5	4	4	2	2	1
	(27.8)	(22.2)	(22.2)	(11.1)	(11.1)	(5.6)
High stage neuroendocrine neoplasia	16	7	14	1	2	4
	(36.4)	(15.9)	(31.8)	(2.3)	(4.5)	(9.1)
Ampullary cancer	0	0	0	0	0	51
	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(100)
Total	452	81	87	29	9	60
	(63.0)	(11.3)	(12.1)	(4.0)	(1.3)	(8.4)

IPMN: Intraductal papillary mucinous neoplasia.